CD8A and neoplasm: In syngeneic mouse tumor models, intratumoral injection of JNJ-4412 results in significant antitumor efficacy, including increased levels of various proinflammatory cytokines in the tumor and the plasma, increased number of CD8 + T cells in the tumors, loss of angiogenesis, and increased apoptosis (Smith et al. 2020).